论文部分内容阅读
老年冠心病合并高脂血症在临床治疗中十分常见,调整血脂水平可以有效防止斑块破裂,降低冠心病致死致残几率。阿托伐他汀中含有选择性的HGM-CoA还原酶抑制剂,能够加快高密度脂蛋白胆固醇(HDL-C)代谢清除,降低血液中血清总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C),能够有效地降低血脂水平。目前文献关于降脂治疗冠心病的报道比较多,但是对于老年冠心病患者合并高脂血症治疗的安全性与剂量方面研
Elderly coronary heart disease with hyperlipidemia is very common in clinical treatment, blood lipid levels can be adjusted to prevent plaque rupture and reduce the risk of death from disability of coronary heart disease. Atorvastatin contains a selective inhibitor of HGM-CoA reductase, which can accelerate the clearance of HDL-C and reduce the levels of TC, LDL- C), can effectively reduce blood lipid levels. The current literature on lipid-lowering treatment of coronary heart disease more reports, but for elderly patients with coronary heart disease in the treatment of hyperlipidemia safety and dose of research